Tarsus Pharmaceuticals, Inc. (26) | License Agreements (5)
Recent Contracts
-
Amended and Restated License Agreement, dated June 3, 2022, by and between the Registrant and Elanco Tiergesundheit AG
(Filed With SEC on August 11, 2022)
-
Development and license Agreement, between the Registrant and LianBio Ophthalmology, dated as of March, 26, 2021
(Filed With SEC on May 11, 2021)
-
License Agreement, dated January 31, 2019, between the Registrant and Elanco Tiergesundheit AG
(Filed With SEC on October 9, 2020)
-
Amendment to License Agreement, dated September 3, 2020, between the Registrant and Elanco Tiergesundheit AG
(Filed With SEC on October 9, 2020)
-
License Agreement, dated September 3, 2020, between the Registrant and Elanco Tiergesundheit AG
(Filed With SEC on October 9, 2020)